Showing results (171-180 of 255) with videos related to
Sort By:
Pageof 26
Fertility and Sterility|April 1, 2011
Extent of metabolic risk in adolescent girls with features of polycystic ovary syndromeRoger Hart, Dorota A Doherty, Trevor Mori, et al.Irish Journal of Medical Science|February 10, 2022
Using menopausal hormone therapy after a cancer diagnosis in IrelandFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.Gynecologic Oncology|October 23, 2024
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 24 months after premenopausal risk-reducing salpingo-oophorectomy (RRSO)Martha Hickey, Alison H Trainer, Efrosinia O Krejany, et al.Reproductive Sciences (Thousand Oaks, Calif.)|May 19, 2016
Differential Gene Expression in Menstrual Endometrium From Women With Self-Reported Heavy Menstrual BleedingJane E Girling, Michelle G Lockhart, Moshe Olshansky, et al.Lancet (London, England)|November 11, 2022
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trialAmanda Vrselja, Ardian Latifi, Rodney J Baber, et al.Breast Cancer Research and Treatment|January 8, 2017
Body size from birth through adolescence in relation to risk of benign breast disease in young womenCatherine S Berkey, Bernard Rosner, Rulla M Tamimi, et al.Journal of the Endocrine Society|August 18, 2020
ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary SyndromeDonna F Vine, Lawrence J Beilin, Sally Burrows, et al.The Lancet. Healthy Longevity|December 25, 2025
Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysisMelissa Melville, Lexi He, Roopal Desai, et al.The Journal of Clinical Endocrinology and Metabolism|July 6, 2023
WHAM-A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomySarah A L Price, Sue Finch, Efrosinia Krejany, et al.Contemporary Clinical Trials Communications|December 6, 2021
The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer - Trial protocol of a phase II studyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.Pageof 26